A woman with erythematous rash over flexures and face: tofacitinib-induced symmetrical drug-related intertriginous and flexural exanthema.

IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL

BMJ Case Reports Pub Date : 2025-05-22 DOI:10.1136/bcr-2025-265572

Avik Mondal, Peeyush Kiran Tripathy, Aparna Palit

引用次数: 0

Abstract

Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) is a rare drug-induced cutaneous adverse event due to antibiotics, antifungals or antiepileptics. Tofacitinib, a JAK inhibitor, is administered for various dermatological and rheumatological diseases. Here, we report a rare cutaneous adverse event (SDRIFE) in a young female resulting from tofacitinib taken for her juvenile idiopathic arthritis.

查看原文本刊更多论文

女性屈曲和面部红斑皮疹：托法替尼引起的对称药物相关性三叉间和屈曲疹。

对称性药物相关性三叉间曲疹（SDRIFE）是一种罕见的由抗生素、抗真菌药物或抗癫痫药物引起的药物性皮肤不良事件。托法替尼是一种JAK抑制剂，用于治疗各种皮肤病和风湿病。在这里，我们报告一个罕见的皮肤不良事件（SDRIFE）在一个年轻的女性由于服用托法替尼她的幼年特发性关节炎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMJ Case Reports Medicine-Medicine (all)

CiteScore

1.40

自引率

0.00%

发文量

1588

期刊介绍： BMJ Case Reports is an important educational resource offering a high volume of cases in all disciplines so that healthcare professionals, researchers and others can easily find clinically important information on common and rare conditions. All articles are peer reviewed and copy edited before publication. BMJ Case Reports is not an edition or supplement of the BMJ.